Delivery Order SPE2DR25D1053-SPE2DR26FT415
- Not listed
- The Defense Logistics Agency awarded a $69,558.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers....
- The Defense Logistics Agency awarded a $5,536.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, demonstrating AmerisourceBergen's continued capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a ceiling value of $13,037.38. This firm fixed-price delivery order is scheduled for completion by October 27, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,247.80 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $7,020.34 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The delivery order, which represents a child contract under a larger vehicle, has an ultimate completion date of October 23, 2025. This non-set-aside award reflects a competitive procurement process for pharmaceutical supplies supporting military and federal healthcare systems. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a ceiling value of $1,135.11. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a small-value transaction within the pharmaceutical supply chain. The award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $4,803.48 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's established capability...
- The Defense Logistics Agency awarded a delivery order valued at $7,803.93 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price, non-competitive delivery order is scheduled for completion by August 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $26,823.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will take...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,749.27 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract was executed on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award utilizes firm fixed pricing under a delivery order contract type, reflecting a relatively small...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT415Delivery Order
The Defense Logistics Agency awarded a $67,838.22 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued without a set-aside designation through competitive procedures, is scheduled for completion by October 30, 2025, with performance based at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, particularly in support of military and veteran healthcare systems. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. Repatha, a specialty medication used for cholesterol management, reflects the company's role in providing critical brand-name medications across multiple therapeutic domains to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $67.8k | 10/29/25 |